These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 10417407)

  • 1. Crystallographic analysis of potent and selective factor Xa inhibitors complexed to bovine trypsin.
    Whitlow M; Arnaiz DO; Buckman BO; Davey DD; Griedel B; Guilford WJ; Koovakkat SK; Liang A; Mohan R; Phillips GB; Seto M; Shaw KJ; Xu W; Zhao Z; Light DR; Morrissey MM
    Acta Crystallogr D Biol Crystallogr; 1999 Aug; 55(Pt 8):1395-404. PubMed ID: 10417407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin.
    Stubbs MT; Huber R; Bode W
    FEBS Lett; 1995 Nov; 375(1-2):103-7. PubMed ID: 7498454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, characterization, and the crystal structure of the inhibitor ZK-807834 (CI-1031) complexed with factor Xa.
    Adler M; Davey DD; Phillips GB; Kim SH; Jancarik J; Rumennik G; Light DR; Whitlow M
    Biochemistry; 2000 Oct; 39(41):12534-42. PubMed ID: 11027132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel factor Xa inhibitor: structure-activity relationships and selectivity between factor Xa and thrombin.
    Katakura S; Nagahara T; Hara T; Iwamoto M
    Biochem Biophys Res Commun; 1993 Dec; 197(2):965-72. PubMed ID: 8267636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for inhibition promiscuity of dual specific thrombin and factor Xa blood coagulation inhibitors.
    Nar H; Bauer M; Schmid A; Stassen JM; Wienen W; Priepke HW; Kauffmann IK; Ries UJ; Hauel NH
    Structure; 2001 Jan; 9(1):29-37. PubMed ID: 11342132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.
    Renatus M; Bode W; Huber R; Stürzebecher J; Stubbs MT
    J Med Chem; 1998 Dec; 41(27):5445-56. PubMed ID: 9876114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of human factor Xa complexed with potent inhibitors.
    Maignan S; Guilloteau JP; Pouzieux S; Choi-Sledeski YM; Becker MR; Klein SI; Ewing WR; Pauls HW; Spada AP; Mikol V
    J Med Chem; 2000 Aug; 43(17):3226-32. PubMed ID: 10966741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urethanyl-3-amidinophenylalanine derivatives as inhibitors of factor Xa. X-ray crystal structure of a trypsin/inhibitor complex and modeling studies.
    Sperl S; Bergner A; Stürzebecher J; Magdolen V; Bode W; Moroder L
    Biol Chem; 2000 Apr; 381(4):321-9. PubMed ID: 10839461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and activity of a novel series of factor Xa inhibitors: optimization of arylamidine groups.
    Phillips G; Guilford WJ; Buckman BO; Davey DD; Eagen KA; Koovakkat S; Liang A; McCarrick M; Mohan R; Ng HP; Pinkerton M; Subramanyam B; Ho E; Trinh L; Whitlow M; Wu S; Xu W; Morrissey MM
    J Med Chem; 2002 Jun; 45(12):2484-93. PubMed ID: 12036356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and activity of 2,6-diphenoxypyridine-derived factor Xa inhibitors.
    Phillips G; Davey DD; Eagen KA; Koovakkat SK; Liang A; Ng HP; Pinkerton M; Trinh L; Whitlow M; Beatty AM; Morrissey MM
    J Med Chem; 1999 May; 42(10):1749-56. PubMed ID: 10346927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed cation-pi mediated binding by factor Xa: a novel enzymatic mechanism for molecular recognition.
    Lin Z; Johnson ME
    FEBS Lett; 1995 Aug; 370(1-2):1-5. PubMed ID: 7649284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure of tick anticoagulant peptide at 1.6 A resolution complexed with bovine pancreatic trypsin inhibitor.
    St Charles R; Padmanabhan K; Arni RV; Padmanabhan KP; Tulinsky A
    Protein Sci; 2000 Feb; 9(2):265-72. PubMed ID: 10716178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
    Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
    J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstructing the binding site of factor Xa in trypsin reveals ligand-induced structural plasticity.
    Reyda S; Sohn C; Klebe G; Rall K; Ullmann D; Jakubke HD; Stubbs MT
    J Mol Biol; 2003 Jan; 325(5):963-77. PubMed ID: 12527302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution structures of three new trypsin-squash-inhibitor complexes: a detailed comparison with other trypsins and their complexes.
    Helland R; Berglund GI; Otlewski J; Apostoluk W; Andersen OA; Willassen NP; Smalås AO
    Acta Crystallogr D Biol Crystallogr; 1999 Jan; 55(Pt 1):139-48. PubMed ID: 10089404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of potent and selective amidino bicyclic factor Xa inhibitors.
    Han Q; Dominguez C; Stouten PF; Park JM; Duffy DE; Galemmo RA; Rossi KA; Alexander RS; Smallwood AM; Wong PC; Wright MM; Luettgen JM; Knabb RM; Wexler RR
    J Med Chem; 2000 Nov; 43(23):4398-415. PubMed ID: 11087565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of two potent nonamidine inhibitors bound to factor Xa.
    Adler M; Kochanny MJ; Ye B; Rumennik G; Light DR; Biancalana S; Whitlow M
    Biochemistry; 2002 Dec; 41(52):15514-23. PubMed ID: 12501180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitors.
    Huang W; Zhang P; Zuckett JF; Wang L; Woolfrey J; Song Y; Jia ZJ; Clizbe LA; Su T; Tran K; Huang B; Wong P; Sinha U; Park G; Reed A; Malinowski J; Hollenbach SJ; Scarborough RM; Zhu BY
    Bioorg Med Chem Lett; 2003 Feb; 13(3):561-6. PubMed ID: 12565972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding protein-ligand interactions: the price of protein flexibility.
    Rauh D; Klebe G; Stubbs MT
    J Mol Biol; 2004 Jan; 335(5):1325-41. PubMed ID: 14729347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.